Tocvan Ventures Corp.
TCVNF
$0.35
$0.0412.90%
| Weiss Ratings | TCVNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | TCVNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Fair | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | TCVNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.23 | |||
| Price History | TCVNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 2.94% | |||
| 60-Day Total Return | -11.10% | |||
| 90-Day Total Return | -27.61% | |||
| Year to Date Total Return | -2.78% | |||
| 1-Year Total Return | 5.20% | |||
| 2-Year Total Return | -10.03% | |||
| 3-Year Total Return | -49.55% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -27.61% | |||
| 52-Week Low % Change | 78.21% | |||
| Price | TCVNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.48 | |||
| 52-Week Low Price | $0.20 | |||
| 52-Week Low Price (Date) | Mar 21, 2024 | |||
| 52-Week High Price (Date) | Oct 24, 2024 | |||
| Valuation | TCVNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 21.26M | |||
| Enterprise Value | 21.48M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.02 | |||
| Earnings Per Share Growth | -53.67% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | 3.27 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.35 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -23.89 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | TCVNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 51.50M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | TCVNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 888 772 2452 | |||
| Address | 1130 West Pender Street Vancouver, BC V6E 4A4 | |||
| Website | tocvan.com | |||
| Country | Canada | |||
| Year Founded | 2018 | |||
| Profitability | TCVNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | TCVNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -8.18% | |||
| Return on Equity | -- | |||
| Income Statement | TCVNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -860.90K | |||
| Net Income (TTM) | -1.12M | |||
| Net Income Avl. to Common (TTM) | -1.12M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 20.84% | |||
| EPS Diluted (TTM) | -0.02 | |||
| EPS Diluted Growth (Q YOY) | 38.26% | |||
| Balance Sheet | TCVNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 390.60K | |||
| Cash Per Share (Q) | $0.01 | |||
| Total Current Assets (Q) | 479.60K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 5.52M | |||
| Current Ratio (Q) | 0.277 | |||
| Book Value Per Share (Q) | $0.11 | |||
| Total Assets (Q) | 7.25M | |||
| Total Current Liabilities (Q) | 1.73M | |||
| Total Debt (Q) | 614.10K | |||
| Total Liabilities (Q) | 1.73M | |||
| Total Common Equity (Q) | 5.52M | |||
| Cash Flow | TCVNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -1.16M | |||
| Cash from Financing (TTM) | 1.76M | |||
| Net Change in Cash (TTM) | -224.00K | |||
| Levered Free Cash Flow (TTM) | -1.58M | |||
| Cash from Operations (TTM) | -823.50K | |||
